Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells

Kidney International

Volumn 65, Issue 2, 2004, Pages 452-458

  Fishbane, Steven ^a   Ragolia, Louis ^a   Palaia, Thomas ^a   Johnson, Barbra ^a   Elzein, Hafez ^a   Maesaka, John K ^a  

^a NONE

Author keywords

Apoptosis; Cytoprotection; Erythropoietin

Indexed keywords

CAMPTOTHECIN; CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; HYDROGEN PEROXIDE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROSTAGLANDIN D2 DERIVATIVE; PROSTAGLANDIN SYNTHASE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPROTECTION; DRUG EFFECT; ENZYME ACTIVITY; HYPOXIC CELL; KIDNEY CELL; KIDNEY TUBULE CELL; MESANGIUM CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 1642480073     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00400.x     Document Type: Article

References (40)

1. GREGORY CJ, EAVES AC: Human marrow cells capable of erythropoietic differentiation in vitro: Definition of three erythroid colony responses. Blood 49:855-864, 1977
2. GREGORY CJ, EAVES AC: Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 51:527-537, 1978
3. LACOMBE C, MAYEUX P: The molecular biology of erythropoietin. Nephrol Dial Transplant 14(Suppl 2):22-28, 1999
4. MACDOUGALL IC: Novel erythropoiesis stimulating protein. Semin Nephrol 20:375-381, 2000
5. ANAGNOSTOU A, LIU Z, STEINER M, et al: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-3978, 1994
6. AMMARGUELLAT F, GOGUSEV J, DRUEKE TB: Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 11:687-692, 1996
7. YASUDA Y, MASUDA S, CHIKUMA M, et al: Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273:25381-25387, 1998
8. BRINES ML, GHEZZI P, KEENAN S, et al: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531, 2000
9. SIREN AL, KNERLICH F, POSER W, et al: Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berlin) 101:271-276, 2001
10. SIREN AL, FRATELLI M, BRINES M, et al: Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044-4049, 2001
11. JUNK AK, MAMMIS A, SAVITZ SI, et al: Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99:10659-10664, 2002
12. STROKA DM, BURKHARDT T, DESBAILLETS I: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453, 2001
13. CHONG ZZ, KANG JQ, MAIESE K: Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22:503-514, 2002
14. MAESAKA JK, PALAIA T, FRESE L, et al: Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells. Kidney Int 60:1692-1698, 2001
15. CAHIR-MCFARLAND ED, DAVIDSON DM, SCHAUER SL, et al: NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97:6055-6060, 2000
16. WESTENFELDER C, BIDDLE DL, BARANOWSKI RL: Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55:808-820, 1999
17. ROSENBERGER C, MANDRIOTA S, JURGENSEN JS, et al: Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13:1721-1732, 2002
18. SMITH PK, KROHN RI, HERMANSON GT, et al: Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85, 1985
19. BAUER C: Erythropoietin - From gene structure to therapeutic applications. J Perinat Med 23:77-81, 1995
20. MUTA K, KRANTZ SB, BONDURANT MC, et al: Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94:34-43, 1994
21. ALJAMA P, BOMMER J, CANAUD B, et al: Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant 16 (Suppl 3):22-28, 2001
22. MACDOUGALL IC: An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 16 (Suppl 3):14-21, 2001
23. MACDOUGALL IC: Novel erythropoiesis stimulating protein. Semin Nephrol 20:375-381, 2000
24. JELKMANN W: Biology of erythropoietin. Clin Invest 72:S3-S10, 1994
25. LEWCZUK P, HASSELBLATT M, KAMROWSKI-KRUCK H, et al: Survival of hippocampal neurons in culture upon hypoxia: Effect of erythropoietin. Neuroreport 11:3485-3488, 2000
26. ALAFACI C, SALPIETRO F, GRASSO G, et al: Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol 406:219-225, 2000
27. BUEMI M, GRASSO G, CORICA F, et al: In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J Pharmacol 392:31-34, 2000
28. GRASSO G, BUEMI M, ALAFACI C, et al: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 99:5627-5631, 2002
29. BERNAUDIN M, MARTI HH, ROUSSEL S, et al: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651, 1999
30. SADAMOTO Y, IGASE K, SAKANAKA M, et al: Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253:26-32, 1998
31. SADAMOTO Y, IGASE K, SAKANAKA M, SATO K, et al: Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253:26-32, 1998
32. SAKANAKA M, WEN TC, MATSUDA S, et al: In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95:4635-1640, 1998
33. KURIYAMA S, TOMONARI H, YOSHIDA H, et al: Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77:176-185, 1997
34. JUNGERS P, CHOUKROUN G, OUALIM Z, et al: Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16:307-312, 2001
35. NIGAM S, LIEBERTHAL W: Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol 279:F3-F11, 2000
36. URADE Y, HAYAISHI O: Prostaglandin D synthase: Structure and function. Vitamin Hormones 58:89-120, 2000
37. DEJOSEZ M, RAMP U, MAHOTKA C, et al: Sensitivity to TRAIL/ APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan. Cell Death Differ 7:1127-1136, 2000
38. DAEMEN MA, VAN'T VEER C, DENECKER G, HEEMSKERK VH, et al: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549, 1999
39. LIEBERTHAL W, KOH JS. LEVINE JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol 18:505-518, 1998
40. LIEBERTHAL W, MENZA SA, LEVINE JS: Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274:F315-F327, 1998